Blood Advances, 2473-9529

Journal

1 - 10 out of 17Page size: 10

Publications

  1. Published

    BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines

    Alex Dowell, Graham Taylor, 28 Jan 2020, In: Blood Advances. 4, 2, p. 356-366 11 p.

    Research output: Contribution to journal › Article › peer-review

  2. Published

    Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIba

    Caroline Kardeby, Elizabeth Haining, Ruben Barroso, Ed Rainger, Steve Watson, Yi Sun, 12 Feb 2019, In: Blood Advances.

    Research output: Contribution to journal › Article › peer-review

  3. Published

    Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα

    Caroline Kardeby, Elizabeth Haining, Ruben Barroso, Ed Rainger, Steve Watson, Yi Sun, 12 Feb 2019, In: Blood Advances. 3, 3, p. 275-287 13 p.

    Research output: Contribution to journal › Article › peer-review

  4. Published

    Mixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cells

    Francesca Kinsella, Jianmin Zuo, Charlotte Inman, Hayden Pearce, Suzy Eldershaw & Paul Moss, 12 Mar 2019, In: Blood Advances. 3, 5, p. 734-743 10 p.

    Research output: Contribution to journal › Article › peer-review

  5. Published

    C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia

    Justin Loke, Paulynn Suyin Chin, Peter Keane, Anna Pickin, Salam Assi, Anetta Ptasinska, Maria Imperato, Peter Cockerill & Conny Bonifer, 13 Feb 2018, In: Blood Advances. 2, 3, p. 271-284 14 p.

    Research output: Contribution to journal › Article › peer-review

  6. Published

    The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT

    Francesca Kinsella, Suzy Eldershaw, Charles Craddock, Jianmin Zuo, Ram Malladi & Paul Moss, 21 Aug 2017, In: Blood Advances. 1, 19, p. 1589-1597 9 p.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia

    Sylvie Freeman, 22 Oct 2019, In: Blood Advances. 3, 20, p. 3052-3061 10 p.

    Research output: Contribution to journal › Article › peer-review

  8. Published

    Soluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVI

    Natalie Poulter, Rob Dinsdale, Peter Hampson, Jon Bishop, Tariq Iqbal, Steve Watson, Paul Harrison, 13 Feb 2018, In: Blood Advances. 2, 3, p. 240-251

    Research output: Contribution to journal › Article › peer-review

  9. Published

    Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR

    Suzy Eldershaw, Hayden Pearce, Nathaniel Davies & Paul Moss, 26 Feb 2019, In: Blood Advances. 3, 4, p. 519-530 12 p.

    Research output: Contribution to journal › Article › peer-review

  10. Published

    Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions

    Amanda Dalby, Jeremy Pike, Neil Morgan & Steve Watson, 14 Jul 2020, In: Blood Advances. 4, 13, p. 2953–2961 9 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 Next